Discover the five best-performing stocks of 2025 so far. See which market leaders are driving returns, dominating this year ...

The biggest reason why shares of Alphabet trade at a discount to its peers is that the market is worried about its base ...

Indian equities are bracing for high volatility as key domestic and global triggers — from the RBI policy decision and major ...

Microsoft soared past US$4 trillion in market valuation, becoming the second publicly traded company after Nvidia to surpass ...

Viking Therapeutics ' (NASDAQ: VKTX) shares could rise over the next year by as much as 165% at the midpoint according to some analysts, or even up to 268% at the high end. The company creates drugs ...

In recent forecasts, Vanguard projects the stock market will rise by only 3.3% to 5.3% a year over the next decade.

CrowdStrike’s Falcon Flex subscription model is accelerating multi-module adoption. Find out why CRWD stock is a Buy and my ...

Medtronic is two years shy of being a Dividend King and it has a historically high 3% yield.

Helped by higher advertising and a growing user base on its social media platforms, Meta earned $18.34 billion in the quarter ...

XPO beat estimates on the top and bottom lines in its second-quarter report. After an earlier investment cycle, management ...

Stocks slumped and Treasury yields fell sharply Friday after a weak report on hiring and the latest gyrations in U.S. trade policy shook Wall Street.

Nebius' operational positioning in Europe has strong cost advantages vs. Big Tech hyperscalers. Read why NBIS stock is a ...